Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter, Phenomenex Scratch Each Other s Back

NEW YORK, Aug. 26 - Beckman Coulter and Phenomenex today said they will co-market some of each other's technology.


Beckman will "recommend" that Phenomenex's columns and technical support be used with its System Gold HPLC platform, while Phenomenex will fold System Gold into its own validation process, the companies said.


Phenomenex added that its VWR International unit will sell Beckman's HPLC columns.


No other sales or service changes were announced by either company.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.